Leukostasis and hyperleukocytosis: Difference between revisions

Revision as of 01:20, 21 March 2026

Background

Hyperleukocytosis: WBC >100,000/μL (some define as >50,000)
Leukostasis: Symptomatic hyperleukocytosis — a hematologic emergency
- White cell plugs obstruct microvasculature → end-organ damage
- Most commonly seen with AML or CML in blast crisis (blast cells are larger and stickier than mature WBCs)
- Brain and lungs are most commonly affected organs
20-40% of patients with leukostasis die within first week of presentation
Key distinction: WBC count alone does not predict leukostasis — CLL patients may have WBC >200K without leukostasis because mature lymphocytes are small and deformable

Clinical Features

Fever — present in ~80%; may be from leukostasis-related inflammation or concurrent infection
CNS leukostasis: headache, dizziness, tinnitus, visual disturbances, confusion, ataxia, stupor, coma, intracranial hemorrhage
Pulmonary leukostasis: Respiratory distress, hypoxemia, respiratory failure
- Pearl: ABG may show falsely decreased PaO2 (leukocytes consume O2 in vitro); pulse oximetry is more accurate
Other: Priapism, renal insufficiency, limb ischemia, DIC

Differential Diagnosis

Oncologic Emergencies

Related to Local Tumor Effects

Malignant airway obstruction
Bone metastases and pathologic fractures
Malignant spinal cord compression
Malignant Pericardial Effusion and Tamponade
Superior vena cava syndrome

Related to Biochemical Derangement

Related to Hematologic Derangement

Related to Therapy

Chemotherapy-induced nausea and vomiting
Cytokine release syndrome
Chemotherapeutic drug extravasation
Differentiation syndrome (retinoic acid syndrome) in APML
Stem cell transplant complications
Catheter-related complications
- Tunnel infection
- Exit site infection
- CVC obstruction (intraluminal or catheter tip thrombosis)
- Catheter-related venous thrombosis
- Fracture of catheter lumen
- Oncologic therapy related adverse events

Evaluation

CBC with differential and peripheral smear
DIC labs: PT/INR, PTT, fibrinogen, D-dimer, FDP (DIC in up to 40%)
Tumor lysis syndrome labs: BMP (potassium, calcium, phosphate), uric acid, LDH (TLS in up to 10%)
CXR: interstitial or alveolar infiltrates
CT head if CNS symptoms (hemorrhage or infarction)
Blood and urine cultures if febrile
Avoid transfusing RBCs before cytoreduction — may worsen viscosity and leukostasis symptoms

Management

Hyperleukocytosis (asymptomatic): Hydroxyurea for cytoreduction may suffice
Leukostasis (symptomatic):
- Aggressive IV hydration — prevent dehydration which worsens viscosity
- Chemotherapy — only treatment proven to improve survival; hematology consult immediately
- Hydroxyurea 50-100 mg/kg/day for urgent cytoreduction while awaiting chemotherapy
- Leukapheresis — temporizing measure to rapidly reduce WBC count; use if chemotherapy will be delayed
TLS prophylaxis: Allopurinol or rasburicase, aggressive IV hydration
Broad-spectrum antibiotics — leading cause of death in blast crisis is infection (patients are functionally neutropenic)
Do NOT transfuse RBCs to Hgb >10 until WBC is reduced (increases viscosity)

Disposition

Admit to ICU for symptomatic leukostasis
Immediate hematology/oncology consult for all cases

References

Authors:

@@ Line 1: / Line 1: @@
 ==Background==
-*Hyperleukocytosis is lab abnormality of WBC >50-100K
+*'''Hyperleukocytosis:''' WBC >100,000/μL (some define as >50,000)
-*Blood viscosity increases
+*'''Leukostasis:''' Symptomatic hyperleukocytosis — a hematologic emergency
-*Leukostasis is symptomatic hyperleukocytosis; it is a medical emergency
+**White cell plugs obstruct microvasculature → end-organ damage
-**Most commonly seen with [[AML]] or [[CML]] in blast crisis
+**Most commonly seen with [[AML]] or [[CML]] in blast crisis (blast cells are larger and stickier than mature WBCs)
-**High blast cell count > WBC plugs in microvasculature
+**Brain and lungs are most commonly affected organs
-***Brain and lung are most commonly affected
+*20-40% of patients with leukostasis die within first week of presentation
-*20-40% of patients with leukostasis die within 1st week of presentation
+*'''Key distinction:''' WBC count alone does not predict leukostasis — CLL patients may have WBC >200K without leukostasis because mature lymphocytes are small and deformable
 ==Clinical Features==
-*[[Fever]]
+*'''Fever''' — present in ~80%; may be from leukostasis-related inflammation or concurrent infection
-**80% of patients
+*'''CNS leukostasis:''' [[headache]], [[dizziness]], [[tinnitus]], visual disturbances, [[confusion]], [[ataxia]], stupor, [[coma]], [[intracranial hemorrhage]]
-**May be due to inflammation associated with leukostasis or concurrent infection
+*'''Pulmonary leukostasis:''' [[Respiratory distress]], [[hypoxemia]], [[respiratory failure]]
-*Brain Leukostasis
+**'''Pearl:''' ABG may show falsely decreased PaO2 (leukocytes consume O2 in vitro); pulse oximetry is more accurate
-**[[Headache]]
+*'''Other:''' Priapism, renal insufficiency, limb ischemia, [[DIC]]
-**[[Dizziness]]
-**[[Tinnitus]]
-**[[Visual disturbances]]
-**[[Ataxia]]
-**[[Confusion]]
-**Stupor
-**[[Coma]]
-**Sudden death
-*Pulmonary Leukostasis
-**[[Respiratory distress]]
-**[[Hypoxemia]]
-***[[ABG]] may show falsely decreased PaO2; pulse oximetry is more accurate
-**[[Respiratory failure]]
 ==Differential Diagnosis==
@@ Line 32: / Line 19: @@
 ==Evaluation==
-===Work-Up===
+*CBC with differential and peripheral smear
-*CBC
+*DIC labs: PT/INR, PTT, fibrinogen, D-dimer, FDP (DIC in up to 40%)
-*DIC labs
+*[[Tumor lysis syndrome]] labs: BMP (potassium, calcium, phosphate), uric acid, LDH (TLS in up to 10%)
-**[[DIC]] occurs in up to 40% of patients
+*[[CXR]]: interstitial or alveolar infiltrates
-**FDP, d-dimer, fibrinogen, coags
+*CT head if CNS symptoms (hemorrhage or infarction)
-*[[Tumor Lysis Syndrome]] labs
+*Blood and urine cultures if febrile
-**TLS occurs in up to 10% of patients
+*'''Avoid transfusing RBCs''' before cytoreduction — may worsen viscosity and leukostasis symptoms
-**Chemistry
-**Uric acid
-**Calcium
-**Phosphate
-===Evaluation===
-*High degree of suspicion needed to make the diagnosis
-*WBC count usually >100K; can have symptoms with WBC as low as 50K
-*[[CXR]]
-**Interstial or alveolar infiltrates
 ==Management==
-*Hyperleukocytosis (asymptomatic)
+*'''Hyperleukocytosis (asymptomatic):''' [[Hydroxyurea]] for cytoreduction may suffice
-**[[Hydroxyurea]] may be all that is required
+*'''Leukostasis (symptomatic):'''
-*Leukostasis
+**Aggressive IV hydration — prevent dehydration which worsens viscosity
-**IV hydration
+**'''Chemotherapy''' — only treatment proven to improve survival; hematology consult immediately
-***Prevent dehydration which can worsen condition
+**'''Hydroxyurea''' 50-100 mg/kg/day for urgent cytoreduction while awaiting chemotherapy
-**Chemotherapy
+**'''Leukapheresis''' — temporizing measure to rapidly reduce WBC count; use if chemotherapy will be delayed
-***Only treatment proven to improve survival
+*TLS prophylaxis: [[Allopurinol]] or [[rasburicase]], aggressive IV hydration
-**[[Hydroxyurea]] + leukapheresis
+*Broad-spectrum [[antibiotics]] — leading cause of death in blast crisis is infection (patients are functionally [[neutropenia|neutropenic]])
-***Can be use for cytoreduction if chemo will be delayed
+*'''Do NOT transfuse RBCs''' to Hgb >10 until WBC is reduced (increases viscosity)
-*[[Allopurinol]] may help prevent [[Tumor lysis syndrome]]
-*Consider [[rasburicase]]
-*Broad spectrum [[antibiotics]]
-**The leading cause of death in blast crisis is infection (patients are functionally [[neutropenia|neutropenic]])
 ==Disposition==
-*Admit to ICU
+*Admit to ICU for symptomatic leukostasis
+*Immediate hematology/oncology consult for all cases
+==See Also==
+*[[Tumor lysis syndrome]]
+*[[Neutropenic fever]]
+*[[DIC]]
 ==References==
 <references/>
 [[Category:Heme/Onc]]